ARTERIAL CALCIFICATIONS IN BETA-THALASSEMIA

Citation
A. Aessopos et al., ARTERIAL CALCIFICATIONS IN BETA-THALASSEMIA, Angiology, 49(2), 1998, pp. 137-143
Citations number
21
Categorie Soggetti
Peripheal Vascular Diseas
Journal title
ISSN journal
00033197
Volume
49
Issue
2
Year of publication
1998
Pages
137 - 143
Database
ISI
SICI code
0003-3197(1998)49:2<137:ACIB>2.0.ZU;2-#
Abstract
The purpose of this study was to define the incidence of arterial calc ifications in patients with beta-Thalassemia. beta-thalassemia patient s have been shown to present a high prevalence of angioid streaks and skin lesions characteristic of pseudoxanthoma elasticum (PXE). Given t he fact that vascular involvement in the form of arterial calcificatio ns is also a common manifestation of PXE, the authors investigated rad iographically the presence of arterial calcifications in beta-thalasse mia patients. They studied 40 patients with beta-thalassemia over 30 y ears of age. Forty healthy, age- and sex-matched subjects were chosen as a control group. Radiographs of the tibias were performed in order to disclose arterial calcifications. The occurrence of PXE skin lesion s and of angioid streaks (AS) was also investigated. Arterial calcific ations were detected in the posterior tibial artery in 22 (55%) beta-t halassemia patients and in six (15%) controls (P<0.01 for the comparis on). PXE skin lesions and AS were found in eight (20%) and 21 (52%) pa tients respectively. A total of 34 patients (85%) had at least one of the three lesions, namely, arterial calcifications, angioid streaks, a nd/or PXE-like skin lesions. Stepwise logistic regression analysis did not reveal prognostic value in independent variables such as transfus ions, chelation therapy, pseudoxanthoma elasticum skin lesions and/or angioid streaks, diabetes, hemoglobin, serum ferritin, and uric acid. It was concluded that arterial calcifications are common in older beta -thalassemia patients. This finding could be a manifestation of an acq uired PXE syndrome associated with beta-thalassemia, and consequently, vascular events complicating PXE should be expected in these patients .